The rising interest in GLP-1 drugs for diabetes has led to a discussion about formats: skin-applied devices versus pills . Usually , GLP-1 therapies were exclusively available in pill form, but the development of transdermal delivery provides a different option . Patches might be advantageous for individuals facing challenges swallowing oral medica